Abeona Therapeutics (ABEO) Gross Margin (2011 - 2026)

Abeona Therapeutics' Gross Margin history runs 9 years deep, the most recent figure standing at 69.08% for Q1 2026.

• In Q1 2026, Gross Margin changed N/A year-over-year to 69.08%; the TTM figure through Mar 2026 stood at 70.23% (changed N/A YoY), while the FY2025 annual figure was 73.68%, changed N/A from the prior year.
• Gross Margin for Q1 2026 stood at 69.08%, down from 80.74% in the prior quarter.
• The five-year high for Gross Margin was 80.74% in Q4 2025, with the low at 47.06% in Q4 2022.
• The 4-year median for Gross Margin is 67.04% (2022), against an average of 49.63%.
• Peak annual rise in Gross Margin reached 1000 bps in 2023, while the deepest fall reached 1000 bps in 2023.
• Abeona Therapeutics' Gross Margin stood at 47.06% in 2022, then surged by 217 bps to 55.0% in 2023, then surged by 47 bps to 80.74% in 2025, then dropped by 14 bps to 69.08% in 2026.
• Business Quant data shows ABEO's Gross Margin at 69.08% in Q1 2026, 80.74% in Q4 2025, and 75.0% in Q2 2025.